Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

A family with recurrent sudden death and no clinical clue.

Arad M, Glikson M, El-Ani D, Monserrat-Inglesias L.

Ann Noninvasive Electrocardiol. 2012 Oct;17(4):387-93. doi: 10.1111/anec.12024.

PMID:
23094885
2.

Deadly proposal: a case of catecholaminergic polymorphic ventricular tachycardia.

Heiner JD, Bullard-Berent JH, Inbar S.

Pediatr Emerg Care. 2011 Nov;27(11):1065-8. doi: 10.1097/PEC.0b013e3182360606.

PMID:
22068070
3.

Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia.

Hayashi M, Denjoy I, Extramiana F, Maltret A, Buisson NR, Lupoglazoff JM, Klug D, Hayashi M, Takatsuki S, Villain E, Kamblock J, Messali A, Guicheney P, Lunardi J, Leenhardt A.

Circulation. 2009 May 12;119(18):2426-34. doi: 10.1161/CIRCULATIONAHA.108.829267. Epub 2009 Apr 27.

4.

Left cardiac sympathetic denervation for the management of life-threatening ventricular tachyarrhythmias in young patients with catecholaminergic polymorphic ventricular tachycardia and long QT syndrome.

Schneider HE, Steinmetz M, Krause U, Kriebel T, Ruschewski W, Paul T.

Clin Res Cardiol. 2013 Jan;102(1):33-42. doi: 10.1007/s00392-012-0492-7. Epub 2012 Jul 21.

5.

A de novo novel cardiac ryanodine mutation (Ser4155Tyr) associated with catecholaminergic polymorphic ventricular tachycardia.

Mantziari L, Vassilikos V, Anastasakis A, Kotsaka X, Paraskevaidis S, Styliadis IH, Luria D.

Ann Noninvasive Electrocardiol. 2013 Nov;18(6):571-6. doi: 10.1111/anec.12089. Epub 2013 Oct 23.

PMID:
24147812
6.

A novel cardiac ryanodine receptor gene (RyR2) mutation in an athlete with aborted sudden cardiac death: a case of adult-onset catecholaminergic polymorphic ventricular tachycardia.

Arakawa J, Hamabe A, Aiba T, Nagai T, Yoshida M, Touya T, Ishigami N, Hisadome H, Katsushika S, Tabata H, Miyamoto Y, Shimizu W.

Heart Vessels. 2015 Nov;30(6):835-40. doi: 10.1007/s00380-014-0555-y. Epub 2014 Aug 5.

PMID:
25092222
7.
8.

Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy.

Elliott PM, Sharma S, Varnava A, Poloniecki J, Rowland E, McKenna WJ.

J Am Coll Cardiol. 1999 May;33(6):1596-601.

9.

Clinical and molecular characterization of a cardiac ryanodine receptor founder mutation causing catecholaminergic polymorphic ventricular tachycardia.

Wangüemert F, Bosch Calero C, Pérez C, Campuzano O, Beltran-Alvarez P, Scornik FS, Iglesias A, Berne P, Allegue C, Ruiz Hernandez PM, Brugada J, Pérez GJ, Brugada R.

Heart Rhythm. 2015 Jul;12(7):1636-43. doi: 10.1016/j.hrthm.2015.03.033. Epub 2015 Mar 23.

PMID:
25814417
10.

Mutations in calmodulin cause ventricular tachycardia and sudden cardiac death.

Nyegaard M, Overgaard MT, Søndergaard MT, Vranas M, Behr ER, Hildebrandt LL, Lund J, Hedley PL, Camm AJ, Wettrell G, Fosdal I, Christiansen M, Børglum AD.

Am J Hum Genet. 2012 Oct 5;91(4):703-12. doi: 10.1016/j.ajhg.2012.08.015.

11.

[Catecholinergic ventricular tachycardia in children].

Denjoy I, Postma A, Lupoglazoff JM, Vaksman G, Kamblock J, Leenhardt A, Wilde AA, Guicheney P.

Arch Mal Coeur Vaiss. 2005 May;98(5):506-12. French.

PMID:
15966600
12.

Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia.

Sy RW, Gollob MH, Klein GJ, Yee R, Skanes AC, Gula LJ, Leong-Sit P, Gow RM, Green MS, Birnie DH, Krahn AD.

Heart Rhythm. 2011 Jun;8(6):864-71. doi: 10.1016/j.hrthm.2011.01.048. Epub 2011 Feb 9.

PMID:
21315846
13.

Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia.

Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M, DeSimone L, Coltorti F, Bloise R, Keegan R, Cruz Filho FE, Vignati G, Benatar A, DeLogu A.

Circulation. 2002 Jul 2;106(1):69-74.

14.

Guidelines for the diagnosis and management of Catecholaminergic Polymorphic Ventricular Tachycardia.

Pflaumer A, Davis AM.

Heart Lung Circ. 2012 Feb;21(2):96-100. doi: 10.1016/j.hlc.2011.10.008. Epub 2011 Nov 25. Review.

PMID:
22119737
15.

Ryanodine receptor mutations presenting as idiopathic ventricular fibrillation: a report on two novel familial compound mutations, c.6224T>C and c.13781A>G, with the clinical presentation of idiopathic ventricular fibrillation.

Paech C, Gebauer RA, Karstedt J, Marschall C, Bollmann A, Husser D.

Pediatr Cardiol. 2014 Dec;35(8):1437-41. doi: 10.1007/s00246-014-0950-2. Epub 2014 Jun 21.

PMID:
24950728
16.

High prevalence of exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia mutation-positive family members diagnosed by cascade genetic screening.

Haugaa KH, Leren IS, Berge KE, Bathen J, Loennechen JP, Anfinsen OG, Früh A, Edvardsen T, Kongsgård E, Leren TP, Amlie JP.

Europace. 2010 Mar;12(3):417-23. doi: 10.1093/europace/eup448. Epub 2010 Jan 26.

PMID:
20106799
17.
18.
19.

Postpacing abnormal repolarization in catecholaminergic polymorphic ventricular tachycardia associated with a mutation in the cardiac ryanodine receptor gene.

Nof E, Belhassen B, Arad M, Bhuiyan ZA, Antzelevitch C, Rosso R, Fogelman R, Luria D, El-Ani D, Mannens MM, Viskin S, Eldar M, Wilde AA, Glikson M.

Heart Rhythm. 2011 Oct;8(10):1546-52. doi: 10.1016/j.hrthm.2011.05.016. Epub 2011 May 26.

20.

Screening for ryanodine receptor type 2 mutations in families with effort-induced polymorphic ventricular arrhythmias and sudden death: early diagnosis of asymptomatic carriers.

Bauce B, Rampazzo A, Basso C, Bagattin A, Daliento L, Tiso N, Turrini P, Thiene G, Danieli GA, Nava A.

J Am Coll Cardiol. 2002 Jul 17;40(2):341-9.

Supplemental Content

Support Center